Apellis Pharmaceuticals, Inc.
APLSDelisted May 14, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001492422
Apellis Pharmaceuticals, Inc. was delisted on May 14, 2026; its insiders filed their last Form 4 on May 14, 2026; 324 institutions reported holding it in 13F filings for Q1 2026, worth $5.56B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q1 2022
Institutional positions in Apellis Pharmaceuticals, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 212
- +28 vs. Q4 2021
- Shares held
- 91.0M
- +10.1M (+12.5%) vs. Q4 2021
- Total value
- $4.62B
- +$799.1M (+20.9%) vs. Q4 2021
- New holders
- 52
- 73 more added
- Sold out
- 24
- 64 more reduced
3 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting APLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $10.2K |
| Q1 2026 | 324 | $5.56B |
| Q4 2025 | 280 | $3.17B |
| Q3 2025 | 273 | $2.77B |
| Q2 2025 | 247 | $2.28B |
| Q1 2025 | 255 | $2.80B |
| Q4 2024 | 260 | $4.04B |
| Q3 2024 | 265 | $3.41B |
| Q2 2024 | 263 | $4.43B |
| Q1 2024 | 302 | $6.65B |
| Q4 2023 | 284 | $6.82B |
| Q3 2023 | 256 | $4.34B |
| Q2 2023 | 317 | $9.71B |
| Q1 2023 | 282 | $7.28B |
| Q4 2022 | 244 | $5.20B |
| Q3 2022 | 250 | $6.66B |
| Q2 2022 | 212 | $4.15B |
| Q1 2022 | 212 | $4.62B |
| Q4 2021 | 187 | $3.83B |
| Q3 2021 | 181 | $2.29B |
| Q2 2021 | 205 | $4.08B |
| Q1 2021 | 175 | $2.80B |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Apellis Pharmaceuticals, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Itau Unibanco Holding S.A. | 163 | $8.00K | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 130 | $6.00K | 0.00% | −2−1.5% | Reduced |
| Rockefeller Capital Management L.P. | 111 | $5.00K | 0.00% | −161−59.2% | Reduced |
| Lindbrook Capital, LLC | 93 | $5.00K | 0.00% | +55+144.7% | Added |
| Signaturefd, LLC | 92 | $5.00K | 0.00% | +92 | New |
| Captrust Financial Advisors | 82 | $4.00K | 0.00% | −244−74.8% | Reduced |
| CWM, LLC | 68 | $3.00K | 0.00% | +68 | New |
| Parallax Volatility Advisers, L.P. | 10 | $1.00K | 0.00% | −10,926−99.9% | Reduced |
| Massmutual Trust Co FSB | 19 | $1.00K | 0.00% | +19 | New |
| TCWP LLC | 31 | $1.00K | 0.00% | +31 | New |
| Allworth Financial LP | 4 | $0 | 0.00% | −200−98.0% | Reduced |
| FinTrust Capital Advisors, LLC | 5 | $0 | 0.00% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −343,213−100.0% | Sold out |
| Tri Locum Partners LP | 0 | $0 | 0.00% | −318,269−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −310,594−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −220,000−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −128,514−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −118,558−100.0% | Sold out |
| Castleark Management LLC | 0 | $0 | 0.00% | −53,130−100.0% | Sold out |
| Aufman Associates Inc | 0 | $0 | 0.00% | −46,751−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −41,199−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −38,421−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −32,355−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −30,600−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −13,939−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −9,828−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −9,406−100.0% | Sold out |
| Stonnington Group, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| AlphaCrest Capital Management LLC | 0 | $0 | 0.00% | −8,556−100.0% | Sold out |
| Allstate Corp | 0 | $0 | 0.00% | −6,694−100.0% | Sold out |
| Crown Wealth Group, LLC | 0 | $0 | 0.00% | −5,040−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −2,223−100.0% | Sold out |
| Eaton Vance Management | 0 | $0 | 0.00% | −2,025−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Smith Group Asset Management, LLC | 0 | $0 | 0.00% | −80−100.0% | Sold out |
| Capital Analysts, LLC | 0 | $0 | 0.00% | −57−100.0% | Sold out |
| Asymmetry Capital Management, L.P. | – | – | – | – | Not filed |
| Tygh Capital Management, Inc. | – | – | – | – | Not filed |
| Bell Investment Advisors, Inc | – | – | – | – | Not filed |